Our Blog Melanoma360

Blog - Melanoma360

Featured image for “Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma”
10/15/2023

Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma

October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “That Good Night: Life and Medicine in the Eleventh Hour”
10/13/2023

That Good Night: Life and Medicine in the Eleventh Hour

A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
Blog - Melanoma360
, 
Podcast
Featured image for “Notes from the Lab: Novel targets for immune checkpoint inhibitors”
09/17/2023

Notes from the Lab: Novel targets for immune checkpoint inhibitors

By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
09/12/2023

Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
Blog - Melanoma360
, 
Podcast
Featured image for “In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here”
09/07/2023

In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here

By Kim Margolin, M.D., FACP, FASCO Understanding the principles adjuvant therapy for adult cancers so we can apply this understanding…
Blog - Melanoma360
, 
In Plain English
Featured image for “Clinical Trials Catch Up”
08/15/2023

Clinical Trials Catch Up

Welcome to our new interview series called Clinical Trials Catch Up, an article delivered in a question-and-answer format designed to…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “Dealing with the Emotional Rollercoaster that Follows a Melanoma Diagnosis PART II with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
08/08/2023

Dealing with the Emotional Rollercoaster that Follows a Melanoma Diagnosis PART II with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

Receiving a melanoma diagnosis can be an overwhelming and life-altering experience. The emotional rollercoaster that follows can be intense, as…
Blog - Melanoma360
, 
Podcast
Featured image for “AIM’s Latest Newsletter: The Research Edition, July 2023”
08/01/2023

AIM’s Latest Newsletter: The Research Edition, July 2023

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research. This edition features: Letter from AIM’s…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “I’ve Been Diagnosed With Melanoma…Now What? PART I with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
07/09/2023

I’ve Been Diagnosed With Melanoma…Now What? PART I with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

The test results are back. You’ve talked to the doctor and learned you have melanoma. Whether it’s your first or…
Blog - Melanoma360
, 
Podcast
Featured image for “ASCO Update 2023”
06/27/2023

ASCO Update 2023

What is ASCO? ASCO is the abbreviation for the American Society of Clinical Oncology, and it is simply the professional…
Blog - Melanoma360
, 
Philanthropy
10/15/2023

Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma

October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
Featured image for “Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
10/13/2023

That Good Night: Life and Medicine in the Eleventh Hour

A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
Featured image for “That Good Night: Life and Medicine in the Eleventh Hour”
Blog - Melanoma360
 | 
Podcast
09/17/2023

Notes from the Lab: Novel targets for immune checkpoint inhibitors

By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
Featured image for “Notes from the Lab: Novel targets for immune checkpoint inhibitors”
Blog - Melanoma360
 | 
Melanoma Research
09/12/2023

Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
Featured image for “Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
Blog - Melanoma360
 | 
Podcast
09/07/2023

In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here

By Kim Margolin, M.D., FACP, FASCO Understanding the principles adjuvant therapy for adult cancers so we can apply this understanding…
Featured image for “In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here”
Blog - Melanoma360
 | 
In Plain English
08/15/2023

Clinical Trials Catch Up

Welcome to our new interview series called Clinical Trials Catch Up, an article delivered in a question-and-answer format designed to…
Featured image for “Clinical Trials Catch Up”
Blog - Melanoma360
 | 
Melanoma Research
08/08/2023

Dealing with the Emotional Rollercoaster that Follows a Melanoma Diagnosis PART II with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

Receiving a melanoma diagnosis can be an overwhelming and life-altering experience. The emotional rollercoaster that follows can be intense, as…
Featured image for “Dealing with the Emotional Rollercoaster that Follows a Melanoma Diagnosis PART II with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
Blog - Melanoma360
 | 
Podcast
08/01/2023

AIM’s Latest Newsletter: The Research Edition, July 2023

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research. This edition features: Letter from AIM’s…
Featured image for “AIM’s Latest Newsletter: The Research Edition, July 2023”
Blog - Melanoma360
 | 
Melanoma Research
07/09/2023

I’ve Been Diagnosed With Melanoma…Now What? PART I with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center

The test results are back. You’ve talked to the doctor and learned you have melanoma. Whether it’s your first or…
Featured image for “I’ve Been Diagnosed With Melanoma…Now What? PART I with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center”
Blog - Melanoma360
 | 
Podcast
06/27/2023

ASCO Update 2023

What is ASCO? ASCO is the abbreviation for the American Society of Clinical Oncology, and it is simply the professional…
Featured image for “ASCO Update 2023”
Blog - Melanoma360
 | 
Philanthropy

Recent Posts

Featured image for “Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA”
Nov. 22, 2024

Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA

Featured image for “Meaning-Centered Psychotherapy for Cancer Patients”
Nov. 22, 2024

Meaning-Centered Psychotherapy for Cancer Patients

Featured image for “Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations”
Nov. 05, 2024

Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations

Featured image for “Book Suggestions for Caregivers”
Nov. 04, 2024

Book Suggestions for Caregivers

Featured image for “Turn Hope into Action with AIM at Melanoma”
Oct. 28, 2024

Turn Hope into Action with AIM at Melanoma

Filter by Tag